Shree Ganesh [SGRL] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Shree Ganesh

BSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shree Ganesh wins in 8 metrics, Divi's Laboratories wins in 11 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShree GaneshDivi's LaboratoriesBetter
P/E Ratio (TTM)30.8465.37Shree Ganesh
Price-to-Book Ratio4.6510.13Shree Ganesh
Debt-to-Equity Ratio26.440.03Divi's Laboratories
PEG Ratio-1.192.47Shree Ganesh
EV/EBITDA17.5848.31Shree Ganesh
Profit Margin (TTM)20.16%23.89%Divi's Laboratories
Operating Margin (TTM)19.77%25.60%Divi's Laboratories
EBITDA Margin (TTM)19.77%25.60%Divi's Laboratories
Return on Equity15.89%14.64%Shree Ganesh
Return on Assets (TTM)12.02%12.94%Divi's Laboratories
Free Cash Flow (TTM)$74.69M$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return-38.00%8.12%Divi's Laboratories
Price-to-Sales Ratio (TTM)6.2215.71Shree Ganesh
Enterprise Value$6.85B$1,480.60BDivi's Laboratories
EV/Revenue Ratio6.3215.34Shree Ganesh
Gross Profit Margin (TTM)64.62%60.33%Shree Ganesh
Revenue per Share (TTM)$84$363Divi's Laboratories
Earnings per Share (Diluted)$17.03$87.36Divi's Laboratories
Beta (Stock Volatility)0.200.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shree Ganesh vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Shree Ganesh
Divi's Laboratories
Shree Ganesh Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shree Ganesh-3.10%-2.27%-14.23%-10.95%-31.40%-22.63%
Divi's Laboratories2.73%3.10%-4.83%-14.69%1.79%-3.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shree Ganesh-38.00%112.42%294.53%1,442.27%1,442.27%1,442.27%
Divi's Laboratories8.12%57.02%83.89%435.51%1,516.65%7,132.15%

News Based Sentiment: Shree Ganesh vs Divi's Laboratories

Shree Ganesh

News based Sentiment: NEGATIVE

September brought disappointing financial results for Shree Ganesh Remedies, with a significant decline in net profit. Coupled with leadership changes and a falling stock price, the month paints a concerning picture for investors, suggesting potential challenges ahead despite a discounted valuation compared to peers.

View Shree Ganesh News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Divi's Laboratories, with stellar FY25 results overshadowed by a weaker Q1 FY26 performance and fluctuating analyst opinions. The Nifty 50 exclusion adds another layer of complexity, creating a dynamic investment scenario that requires careful monitoring.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Shree Ganesh vs Divi's Laboratories

MetricSGRLDIVISLAB
Market Information
Market Cap i₹6.85B₹1.61T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i6,495437,716
90 Day Avg. Volume i4,949381,180
Last Close₹508.95₹5,866.00
52 Week Range₹494.95 - ₹950.00₹4,955.00 - ₹7,071.50
% from 52W High-46.43%-17.05%
All-Time High₹950.05 (Jul 22, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-46.43%-17.05%
Growth Metrics
Quarterly Revenue Growth-0.01%0.14%
Quarterly Earnings Growth-0.26%0.27%
Financial Health
Profit Margin (TTM) i0.20%0.24%
Operating Margin (TTM) i0.20%0.26%
Return on Equity (TTM) i0.16%0.15%
Debt to Equity (MRQ) i26.440.03
Cash & Liquidity
Book Value per Share (MRQ)₹113.00₹563.87
Cash per Share (MRQ)₹22.01₹132.86
Operating Cash Flow (TTM) i₹337.14M₹19.67B
Levered Free Cash Flow (TTM) i₹230.68M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend i₹0.00₹60.00

Valuation & Enterprise Metrics Analysis: Shree Ganesh vs Divi's Laboratories

MetricSGRLDIVISLAB
Price Ratios
P/E Ratio (TTM) i30.8465.37
Forward P/E iN/A101.43
PEG Ratio i-1.192.47
Price to Sales (TTM) i6.2215.71
Price to Book (MRQ) i4.6510.13
Market Capitalization
Market Capitalization i₹6.85B₹1.61T
Enterprise Value i₹6.85B₹1.48T
Enterprise Value Metrics
Enterprise to Revenue i6.3215.34
Enterprise to EBITDA i17.5848.31
Risk & Other Metrics
Beta i0.200.18
Book Value per Share (MRQ) i₹113.00₹563.87

Financial Statements Comparison: Shree Ganesh vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SGRLDIVISLAB
Revenue/Sales i₹246.68M₹24.10B
Cost of Goods Sold i₹87.28M₹9.56B
Gross Profit i₹159.40M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹48.77M₹6.17B
EBITDA i₹79.58M₹8.48B
Pre-Tax Income i₹45.98M₹7.33B
Income Tax i₹11.53M₹1.88B
Net Income (Profit) i₹34.45M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SGRLDIVISLAB
Cash & Equivalents i₹99.43M₹4.15B
Total Current Assets i₹775.75M₹100.81B
Total Current Liabilities i₹161.82M₹14.52B
Long-Term Debt i₹296.08M₹20.00M
Total Shareholders Equity i₹1.45B₹149.69B
Retained Earnings i₹1.10B₹134.00B
Property, Plant & Equipment i₹31.57M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SGRLDIVISLAB
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGRLDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,495437,716
Average Daily Volume (90 Day) i4,949381,180
Shares Outstanding i12.84M265.47M
Float Shares i2.20M120.77M
% Held by Insiders i0.76%0.52%
% Held by Institutions i0.00%0.29%

Dividend Analysis & Yield Comparison: Shree Ganesh vs Divi's Laboratories

MetricSGRLDIVISLAB
Last 12-Month Dividend i₹0.00₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend i₹0.33₹50.00
3-Year Avg Dividend Yield i0.15%0.70%
3-Year Total Dividends i₹1.00₹150.00
Ex-Dividend DateSep 07, 2023Jul 25, 2025